Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

NCT06723548 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Myasthenia Gravis
Autoimmune Diseases

Interventions

DRUG: Telitacicept

Sponsor

First Affiliated Hospital of Wenzhou Medical University